Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,370
Closed -$212K 376
2026
Q1
$212K Sell
3,370
-175
-5% -$12.2K 0.01% 332
2025
Q4
$235K Buy
3,545
+320
+10% +$20.7K 0.02% 316
2025
Q3
$217K Sell
3,225
-214
-6% -$16.9K 0.01% 316
2025
Q2
$300K Buy
3,439
+219
+7% +$17.2K 0.02% 293
2025
Q1
$220K Sell
3,220
-815
-20% -$66.5K 0.02% 316
2024
Q4
$314K Sell
4,035
-60
-1% -$4.44K 0.02% 283
2024
Q3
$275K Buy
4,095
+345
+9% +$28.3K 0.02% 294
2024
Q2
$425K Buy
3,750
+200
+6% +$25.3K 0.03% 253
2024
Q1
$492K Buy
3,550
+1,920
+118% +$241K 0.04% 243
2023
Q4
$202K Buy
+1,630
New +$167K 0.02% 326

Other funds holding DXCM

Simmons Bank's DXCM Position: Q2 2026 in Review

Simmons Bank sold out of DexCom (DXCM) in Q2 2026, closing a stake of 3,370 shares — an estimated $212K sold.

Simmons Bank first reported a position in DXCM in Q4 2023 and held it in 10 quarters. The position peaked at $492K in Q1 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Simmons Bank reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Simmons Bank sold 3,370 DexCom shares in Q2 2026, an estimated $212K.
  • Simmons Bank first reported a position in DexCom in Q4 2023 and held it in 10 quarters.
  • Simmons Bank's DexCom position peaked at $492K in Q1 2024.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Simmons Bank's 13F filing for Q2 2026, filed 31 Jul 2026.